The caspase 3-dependent apoptotic effect of pycnogenol in human oral squamous cell carcinoma HSC-3 cells

In-Hyoung Yang1, Ji-Ae Shin1, Lee-Han Kim1

  • 1Department of Oral Pathology, School of Dentistry, and Institute of Oral Bioscience, Chonbuk National University, Jeonju 561-756, Korea.

Insights

Pycnogenol effectively combats oral cancer by inducing apoptosis in cancer cells. This natural compound shows promise for future chemoprevention and chemotherapy strategies against oral squamous cell carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Oral squamous cell carcinoma (OSCC) is a significant global health concern.
  • Identifying novel therapeutic agents for OSCC chemoprevention and chemotherapy is crucial.

Purpose of the Study:

  • To investigate the apoptotic effects of Pycnogenol on human oral cancer cells (HSC-3).
  • To elucidate the molecular mechanisms underlying Pycnogenol's anti-cancer activity.

Main Methods:

  • Cell viability assays were performed on HSC-3 cells treated with Pycnogenol.
  • Apoptosis markers, including cleaved poly (ADP-ribose) polymerase and caspase 3, were analyzed.
  • Protein levels of Bcl-2 family members and reactive oxygen species (ROS) production were assessed.

Main Results:

  • Pycnogenol significantly inhibited HSC-3 cell viability and neoplastic cell transformation.
  • Pycnogenol induced caspase-dependent apoptosis in a dose-dependent manner.
  • Pycnogenol increased Bak protein stability and induced ROS generation, which was partially blocked by N-acetyl-l-cysteine.

Conclusions:

  • Pycnogenol demonstrates potent anti-cancer properties against human oral squamous cell carcinoma cells.
  • The mechanism involves caspase-dependent apoptosis, modulation of Bak protein, and ROS production.
  • Pycnogenol holds potential as a therapeutic agent for oral cancer chemoprevention or chemotherapy.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.8K